WHO ICTRP trial

Prolonged administration of Intravenous Medication through Midline compared to…

ACTRN12620000724976 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12620000724976
Public title Prolonged administration of Intravenous Medication through Midline compared to Standard peripheral intravenous cannula in children
Scientific title Prolonged administration of Intravenous Medication through Midline compared to Standard peripheral intravenous cannula in children to reduce catheter failure.
Primary sponsor Queenland Children's Hospital
Secondary sponsors Griffith University
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Hospitalised children requiring vascular access; Hospitalised children requiring vascular access;Anaesthesiology - Anaesthetics
Interventions Midline Catheters (MC) MC insertion will be performed by a nurse practitioner or medical officer with demonstrated competence, in a clinical procedure room, using ultrasound, and surgical aseptic non-touch technique. MCs will be Access…
Registration date Jul 7, 2020
Target size 128
Secondary IDs Nil Known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations